Efficacy and safety of the new generation Watchman FLX device compared to the Watchman 2.5: a systematic review and meta-analysis.
(2023)
Journal Article
Najim, M., Reda Mostafa, M., Eid, M. M., Alabdouh, A., Awad, A. K., Elbanna, M., …Mamas, M. A. (in press). Efficacy and safety of the new generation Watchman FLX device compared to the Watchman 2.5: a systematic review and meta-analysis. American Journal of Cardiovascular Disease, 13(5), 291-299
The first-generation Watchman 2.5 (W 2.5) presented several limitations, such as challenges in implantation within complex left atrial appendage (LAA) anatomies, higher incidence of peri-device leak, device recapture, and device-related thrombus (DR... Read More about Efficacy and safety of the new generation Watchman FLX device compared to the Watchman 2.5: a systematic review and meta-analysis..